Buscopan Co 20 mg/2.5 g Injection
PDF Leaflet Revision Date: 03 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Acute, severe colicky pains of the biliary, urinary and gastro-intestinal tract.
Dosage (summary)
1 ampoule (5 ml) IV slowly; may repeat 2-3 times daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if benefits outweigh risks; avoid during breastfeeding if possible.
Key Drug Interactions
- Methotrexate
- Chlorpromazine
- Acetylsalicylic acid
- Bupropion
- Cyclosporin
Contraindications
- Hypersensitivity to pyrazolone
- Granulocytopenia
- Analgesic-induced asthma
- Acute intermittent hepatic porphyria
- Glaucoma
- Prostate hypertrophy
- Myasthenia gravis
- Pregnancy (3rd trimester)
- Children under 12 months
Common side effects
- Dry mouth
- Hypotension
- Dizziness
- Anaphylactic reactions
Counselling Points
- Monitor for signs of blood dyscrasia
- Avoid alcohol
- Report severe skin reactions immediately
- Do not drive if drowsy
Serious warnings
- Risk of agranulocytosis
- Severe skin reactions
- Hypotensive reactions
- Anaphylactic shock
Important Disclaimer
The Buscopan Co 20 mg/2.5 g Injection professional information leaflet below is the property of Sanofi-Aventis South Africa _ and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
